Trial Profile

A registrational study of LX2006

Status: Planning

Phase of Trial: Phase III

Latest Information Update: 21 Oct 2025

Price :

$35 ^*

Note:

Adis is an information provider.
Final gross price and currency may vary according to local VAT and billing address.
Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

Drugs LX 2006 (Primary)
Indications Cardiomyopathies
Focus Registrational; Therapeutic Use

Most Recent Events

14 Aug 2025 According to Lexeo media release, the company expects final alignment with FDA on the LX2006 registrational study in late Q3 to early Q4 2025.
19 May 2025 New trial record
12 May 2025 According to Lexeo media release, Q2 2025, Lexeo expects to begin enrollment in a prospective natural history study serving as a concurrent external control arm for the registrational study.

You need to be a logged in or subscribed to view this content

If your organization or you do not have a subscription, try one of the following:

Contacting your organization’s admin about adding this content to your AdisInsight subscription
Buying a PDF version of any individual profile
Request a free trial (opens in a new window)

If your organization has a subscription, there are several access options, even while working remotely:

Working within your organization’s network
Login with username/password or try to access via your institution
Persisted access using your organization’s identifier stored in your user browser for 90 days

For assistance, contact us at asktheexpert.adisinsight@springer.com